Successful treatment of severe complicated measles with non-specific transfer factor.
Severe complicated measles has a high mortality rate and no specific treatment. Ten patients with complicated measles - 9 infants with respiratory failure and a 15 year old boy with encephalitis - received immunotherapy with Non-specific Transfer Factor (NTF). The patients had variable degrees of undernourishment and were severely ill when immunotherapy was started. 8/9 cases with respiratory failure were cured. One died of bronchoaspiration while recovering from the measles. The case with encephalitis showed no neurological sequelae two weeks after receiving the last dose of NTF. Treatment of complicated measles with NTF in these patients seemed very effective and deserves further trial.
Ferrer-Argote
V E
VE
Department of Hematology, Hospital General de Mexico, DF, Mexico.
Romero-Cabello
R
R
Hernández-Mendoza
L
L
Arista-Viveros
A
A
Rojo-Medina
J
J
Balseca-Olivera
F
F
Fierro
M
M
Gonzalez-Constandse
R
R
D000293:Adolescent; D001424:Bacterial Infections / Q000150:complications; D002180:Candidiasis, Oral / Q000150:complications; D002644:Chickenpox / Q000150:complications; D002675:Child, Preschool; D018792:Encephalitis, Viral / Q000628:therapy / Q000821:virology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D007223:Infant; D008297:Male; D008457:Measles / Q000150:complications / Q000628:therapy*; D008590:Meningoencephalitis / Q000628:therapy / Q000821:virology; D009748:Nutrition Disorders / Q000150:complications; D012131:Respiratory Insufficiency / Q000628:therapy / Q000821:virology; D014165:Transfer Factor / Q000627:therapeutic use*
D014165:Transfer Factor